Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Milenko Medakovic"'
Publikováno v:
Journal of Asthma. 23:251-260
The effects of labetalol, metoprolol, and placebo on pulmonary function and their interaction with isoproterenol were evaluated in 18 patients with reversible bronchial asthma [isoproterenol-induced increase in forced expiratory volume in 1 second (F
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65480f85af6a1ee252a62639f6f74416
https://doi.org/10.3109/02770908609073169
https://doi.org/10.3109/02770908609073169
Publikováno v:
Clinical Pharmacology and Therapeutics. 46:445-450
Dilevalol, an agent that combines nonselective beta-blocking and beta 2-mediated vasodilating properties, was compared with placebo in 16 subjects with moderate hypertension in a double-blind crossover study. Dilevalol or a placebo was administered i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de492c5092fc32d45453078a878728ec
https://doi.org/10.1038/clpt.1989.163
https://doi.org/10.1038/clpt.1989.163
Publikováno v:
The American Journal of Medicine. 75:47-53
The antihypertensive effects of oral labetalol compared with placebo were evaluated in 74 mildly hypertensive patients (standing diastolic blood pressure 95 to 110 mm Hg) in a bicentric double-blind parallel group study. Following a four-week placebo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bd9c1ec40f821198da8f5cf66f598e1
https://doi.org/10.1016/0002-9343(83)90136-5
https://doi.org/10.1016/0002-9343(83)90136-5
Autor:
Nicolas D. Vlachakis, John W. Bar, Robert F. Maronde, Milenko Medakovic, Nicola Zampaglione, Daniel C. Robinson, Menger Chung
Publikováno v:
The American journal of medicine. 75(4A)
This was an open-label, two-phase crossover study of labetalol in 11 patients with mild to moderate hypertension. A two- to four-week outpatient placebo phase was followed by a three-day inpatient placebo period. Patients were then randomly assigned
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::340913ff0aef07a99888b7230b67b43e
https://pubmed.ncbi.nlm.nih.gov/6356898
https://pubmed.ncbi.nlm.nih.gov/6356898
Publikováno v:
The American journal of medicine. 75(4A)
Labetalol, a new alpha- and beta-adrenergic blocking agent, was administered to 57 patients with essential hypertension whose standing diastolic blood pressure was 105 to 120 mm Hg after three and four weeks of placebo therapy and greater than 90 mm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8cd06b65ec34999e5df1f64aa35ec96
https://pubmed.ncbi.nlm.nih.gov/6356902
https://pubmed.ncbi.nlm.nih.gov/6356902